Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 21, 1999International Journal of Cancer

Molecular mediators of tumor angiogenesis: Enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAndrea KranzCenter for Systems Biology DresdenTMTorsten MattfeldtUniversity Hospital UlmJWJohannes WaltenbergerInterventional Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kranz et al. (1999) studied this question.

synapsesocial.com/papers/6a7379a37af34f94aaa72b5dhttps://doi.org/10.1002/(sici)1097-0215(19990621)84:3<293::aid-ijc16>3.0.co;2-t
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma1992 · 1,797 citations
  2. 2Prognostic factors for breast cancer: have they met their promise?1992 · 59 citations
  3. 3Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.1994 · 1,672 citations
  4. 4Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.1991 · 489 citations
  5. 5Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate1998 · 448 citations